Headed to the NCPA 2019 Annual Convention & Expo? Cannabis and the Role of the Pharmacist Plan to Attend the PPSI Breakfast Symposium 4.0 CE hrs Saturday, October 26, 2019 7 a.m. - 12:30 p.m Marriott Marquis San Diego Salon C Ballroom Registration Fees: FREE for PPSI Supporters $299 - Healthcare Professional $50 - [...]
FDA Public Hearing: Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, May 31, 2019 The Food and Drug Administration has announced a public hearing to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds. The public [...]
http://www.marinij.com/general-news/20170215/marin-marijuana-legalization-debated-on-ij-forums Don Carney says he prefers to call the legalization of marijuana the “corporatization” of cannabis. That’s because, as laws are relaxed and it becomes more readily available, the active ingredient — tetrahydrocannabinol, or THC — is working its way into all kinds of consumer products, says Carney, director of restorative services and the Marin [...]
The Bureau of Medical Cannabis Regulation (BMCR) and Office of Medical Cannabis Safety (OMCS) will be holding their first pre-regulatory stakeholder meetings this September and October. Discussing issues related to general licensing requirements, and specific concepts related to the regulation of medical cannabis dispensaries, distributors, manufacturers, testing laboratories and transporters. Please join us for one of [...]
PPSI would like to testify in Santa Rosa on September 22, from 2-3 PM PPSI would like to testify on determining standards for packaging, labeling, dosing, potency of medical cannabis, produced as medicine, food, botanical and edibles, labeling, dosing, package contents, public health safety warnings, safety standards, cautions and public; (to mental and physical health [...]
